Here's the latest news from Santéand its portfolio companies
Portfolio
Geneos Therapeutics’ Cancer Vaccine Shows Potential for Shrinking ‘Difficult’ Tumors
November 17, 2023
Santé
Research, sciences subdistrict envisioned near The Domain
November 15, 2023
Santé
Digital health startups need more doctor CEOs
November 9, 2023
Portfolio
How KelaHealth Slashed the Rate of Post-Surgical Complications at Duke
November 6, 2023
Portfolio
Endovascular Engineering, Inc. Announces Positive Initial Results in ENGULF Study for HēloTM Thrombectomy System
October 31, 2023
Portfolio
ABK Biomedical Announces First Patient Treated in its Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma
October 24, 2023
Portfolio
Reimagine Care Announces Investment from Memorial Hermann to Help Transform the Cancer Care and Recovery Experience
October 17, 2023
Portfolio
Why every operating room needs a black box
October 11, 2023
Portfolio
Geneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million
September 28, 2023
Portfolio
Sensorium Therapeutics Appoints Veteran Life Sciences Executive Mr. David Southwell to its Board of Directors
September 13, 2023
Portfolio
Solu Therapeutics Names Philip Vickers President and CEO
September 11, 2023
Santé
Santé Ventures Announces Promotions for Auriel August, MD and Michael Gutbrod, PhD
September 6, 2023
Portfolio
Glyscend Therapeutics Appoints Sapan A. Shah, Ph.D., Accomplished Industry Executive, as Chief Executive Officer
September 6, 2023
Portfolio
Boston Scientifics Farapulse Pulsed Field Ablation System Revolutionizing Cardiac Care
August 29, 2023
Portfolio
Geneos Therapeutics Announces Eight of 34 Patients to Achieve Complete Response, Complete Molecular Response, or, Secondary Resectability in Ongoing Clinical Trial of Personalized Therapeutic Cancer Vaccination in Second Line Advanced Liver Cancer
August 22, 2023
Santé
Can telehealth startups fill the gap in adolescent mental healthcare?
